| Sanjay J Khiani, MD | |
|
10370 Park Rd, Suite 202, Charlotte, NC 28210-8508 | |
| (704) 817-2022 | |
| (704) 817-2024 |
| Full Name | Sanjay J Khiani |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 23 Years |
| Location | 10370 Park Rd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063605293 | NPI | - | NPPES |
| 35337600 | Medicaid | WI | |
| 200874570 | Medicaid | IN | |
| 200340800 | Medicaid | IN | |
| 000000541483 | Other | KY | ANTHEM PIN |
| 9454082 | Other | KY | AETNA PIN |
| Entity Name | Family Allergy Asthma & Sinus Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427318062 PECOS PAC ID: 3779739354 Enrollment ID: O20120814000596 |
News Archive
Clotrimazole is a common ingredient in over-the-counter skin creams. Recent results from the University of Gothenburg, Sweden, now show that it is associated with major environmental risks. "The pharmaceuticals and chemicals in everyday use form a mixture in the ocean that has a direct impact on the growth and reproduction of organisms", says scientist Tobias Porsbring.
Cell Therapeutics, Inc. today announced that it has entered into a securities purchase agreement to sell, subject to certain closing conditions, securities in a registered offering to a single life sciences institutional investor. The Company may use a portion of the net proceeds to fund possible investments in, or acquisitions of, complementary businesses, technologies or products.
The University of Bristol has been awarded £2.7 million by the Medical Research Council (MRC) to create a new research centre which will apply knowledge from genetic analyses to large-scale studies of the health of the population. These investigations will aim to find the factors that are causing disease, which can then be influenced to reduce risk.
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sanjay J Khiani, MD 10370 Park Rd, Suite 202, Charlotte, NC 28210-8508 Ph: (704) 817-2022 | Sanjay J Khiani, MD 10370 Park Rd, Suite 202, Charlotte, NC 28210-8508 Ph: (704) 817-2022 |
News Archive
Clotrimazole is a common ingredient in over-the-counter skin creams. Recent results from the University of Gothenburg, Sweden, now show that it is associated with major environmental risks. "The pharmaceuticals and chemicals in everyday use form a mixture in the ocean that has a direct impact on the growth and reproduction of organisms", says scientist Tobias Porsbring.
Cell Therapeutics, Inc. today announced that it has entered into a securities purchase agreement to sell, subject to certain closing conditions, securities in a registered offering to a single life sciences institutional investor. The Company may use a portion of the net proceeds to fund possible investments in, or acquisitions of, complementary businesses, technologies or products.
The University of Bristol has been awarded £2.7 million by the Medical Research Council (MRC) to create a new research centre which will apply knowledge from genetic analyses to large-scale studies of the health of the population. These investigations will aim to find the factors that are causing disease, which can then be influenced to reduce risk.
Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.
› Verified 7 days ago
Dr. Cheryl Lynn Walker-mcgill, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1404 Beatties Ford Rd, Suite 200, Charlotte, NC 28216 Phone: 704-344-2100 | |
John T Klimas, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 | |
Ekta B. Shah, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10650 Park Rd, Charlotte, NC 28210 Phone: 704-667-3960 | |
Shannon N Chadha, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 | |
Richard S Roberts, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 | |
Dr. John Gray Norris, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2600 E 7th St, Unit A, Charlotte, NC 28204 Phone: 704-372-7900 Fax: 704-376-2216 |